Beth Israel Deaconess Hospital–Plymouth Awarded an ‘A for Patient Safety by the Leapfrog Group
Kevin Coughlin – a health care executive with more than 25 years of experience across community hospitals, academic medical centers and health care systems – has been named President and Chief Executive Officer of Beth Israel Deaconess Hospital–Plymouth (BID Plymouth). Coughlin, who joined BID-Plymouth in 2014 as Senior Vice President of System Development, has served as Interim President and CEO since October 2016. His appointment as President and CEO is effective Monday, June 12, 2017.
As Senior Vice President at BID Plymouth, Coughlin led the hospital’s growth strategy, as well as the hospital’s network of 300 physicians and ambulatory services. Under his leadership, employed physician revenue grew more than twofold over three years, which was instrumental to advancing the hospital’s strong financial footing. Coughlin was also instrumental in working with the hospital’s medical staff to develop and launch a Hospital-Physician Compact to further advance the organization.
Previously, Coughlin served as Senior Vice President at Elliott Health System based in Manchester, New Hampshire, where he oversaw select hospital services, including process improvement, as well as an ambulatory network with more than 500,000 outpatient visits annually. He has also held leadership positions at Boston Medical Center’s Faculty Practice Foundation and Brigham and Women’s Hospital.
“We are delighted to have Kevin assume the role of President and CEO,” said Clark Hinkley, Chair of the Board of Directors of BID Plymouth. “During his tenure as Senior Vice President of System Development and most recently as Interim President, Kevin’s steady hand, vision and ability to bring people together have been tremendous assets to the hospital. Kevin is a talented leader who will help us continue to move the organization forward for the patients and communities we serve.”
“Our community hospitals are essential to Beth Israel Deaconess’ mission of providing high quality, lower cost care close to home,” said Kevin Tabb, MD, CEO of Beth Israel Deaconess. “Kevin is a proven leader with extensive experience in strategy, operations and finance, and a strong commitment to the Plymouth community. Kevin was chosen after a vigorous and comprehensive national search that confirmed he was the most qualified candidate to lead BID Plymouth. We look forward to Kevin’s ongoing contributions to BID Plymouth and the BID system.”
“Beth Israel Deaconess Hospital–Plymouth is a great organization, and I’m honored to have been selected as the hospital’s new president,” Coughlin said. “As part of the BID system, I look forward to continuing our community focus and working to provide our patients with the best health care in the region.”
About Beth Israel Deaconess Hospital–Plymouth
Beth Israel Deaconess Hospital–Plymouth (BID Plymouth) is a non-profit healthcare and hospice provider, serving 250,000 residents of 12 towns in Plymouth and Barnstable Counties. BID Plymouth is a full-service, 170-bed acute care community hospital accredited by The Joint Commission, the College of American Pathologists, the American College of Surgeons Commission on Cancer, and the American College of Radiology.
BID Plymouth is a part of Beth Israel Lahey Health, a health care system that brings together academic medical centers and teaching hospitals, community and specialty hospitals, more than 4,700 physicians and 39,000 employees in a shared mission to expand access to great care and advance the science and practice of medicine through groundbreaking research and education.
